Subjective well-being, craving for cannabis and compliance or medication switch in a randomized double blind study with olanzapine and risperidone
Phase of Trial: Phase III
Latest Information Update: 03 Dec 2009
At a glance
- Drugs Olanzapine; Risperidone
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- Acronyms SUB-CAN-OLA-RIS
- 03 Dec 2009 Trial acronym SUB-CAN-OLA-RIS identified as reported by Netherlands Trial Register.
- 03 Dec 2009 New source identified and integrated (Netherlands Trial Register NTR28).
- 23 Sep 2008 Status changed from not stated to completed.